• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


Supernus Pharmaceuticals Plans Relocation to Expanded Operations Center in Gaithersburg, Maryland

Supernus Pharmaceuticals, a company developing and commercializing products for the treatment of central nervous system diseases, is relocating its headquarters, research and development, and pilot-scale manufacturing operations to an 118,000 square-foot space on Quince Orchard Road in Gaithersburg, Maryland.

The company, which will potentially add up to 160 new jobs over the next five years in Montgomery County, expects to move into the new space in 2019, with construction wrapping up in 2020, according to the Maryland Department of Commerce.

“Supernus is excited to continue its long tenure in Montgomery County and to expand its headquarters in support of our company’s growth,” said Frank Mottola Vice President of Quality, GMP Operations and Information Technology of Supernus Pharmaceuticals.

As an incentive to assist with project costs, the Maryland Department of Commerce approved $800,000 through the Maryland Economic Development Assistance Authority and Fund, which can be conditionally applied to expenses.

Additionally, Montgomery County is providing a $500,000 conditional grant through its Economic Development Fund, and the City of Gaithersburg is providing a grant up to $400,000 through its Economic Development Opportunity Fund.

Maryland Commerce is also providing a $90,000 training grant through the Partnership for Workforce Quality program, which will allow Supernus to train a group of employees on high-tech IT process controls and capabilities.

“For more than two decades, Supernus has been hard at work in Maryland developing medicines that have the potential to help patients around the globe,” said Governor Larry Hogan. “We are pleased that the success of Supernus’ products has led to this expansion and the potential to double its workforce in Montgomery County.”

“Supernus Pharmaceuticals is doing critically important work in creating new medicines for the disciplines of neurology and psychiatry,” said Montgomery County Executive Ike Leggett. “We are very pleased that they are expanding their footprint in the county.”

“Supernus is one of the fastest growing biotech/pharma companies in our region and we are proud to support their continued growth in Maryland," said Maryland Commerce Secretary Mike Gill. “Supernus joins a number of life sciences companies, including Paragon Bioservices, Altimmune, and others, that have expanded their operations in our state over the past year and added a significant number of jobs.”


Exclusive Research